CN101884807A - A kind of preparation method and application of borate glass antibacterial coating with biological activity - Google Patents
A kind of preparation method and application of borate glass antibacterial coating with biological activity Download PDFInfo
- Publication number
- CN101884807A CN101884807A CN2010102090822A CN201010209082A CN101884807A CN 101884807 A CN101884807 A CN 101884807A CN 2010102090822 A CN2010102090822 A CN 2010102090822A CN 201010209082 A CN201010209082 A CN 201010209082A CN 101884807 A CN101884807 A CN 101884807A
- Authority
- CN
- China
- Prior art keywords
- glass
- coating
- biological activity
- borate glass
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 48
- 239000011248 coating agent Substances 0.000 title claims abstract description 41
- 239000005385 borate glass Substances 0.000 title claims abstract description 38
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 32
- 230000004071 biological effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000011521 glass Substances 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 21
- 150000002500 ions Chemical class 0.000 claims abstract description 19
- 230000001954 sterilising effect Effects 0.000 claims abstract description 16
- 239000007943 implant Substances 0.000 claims abstract description 13
- 210000000988 bone and bone Anatomy 0.000 claims description 31
- 210000002449 bone cell Anatomy 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 230000004936 stimulating effect Effects 0.000 claims description 6
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 5
- 229910001431 copper ion Inorganic materials 0.000 claims description 5
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 229910000272 alkali metal oxide Inorganic materials 0.000 claims description 2
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 239000012620 biological material Substances 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 229910052709 silver Inorganic materials 0.000 description 15
- 239000004332 silver Substances 0.000 description 15
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 239000010949 copper Substances 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- YAMJITULHOEKMI-UHFFFAOYSA-N B([O-])([O-])[O-].[Ag+3] Chemical compound B([O-])([O-])[O-].[Ag+3] YAMJITULHOEKMI-UHFFFAOYSA-N 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 210000000963 osteoblast Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 4
- 229940019931 silver phosphate Drugs 0.000 description 4
- 229910000161 silver phosphate Inorganic materials 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 210000002303 tibia Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- -1 silver ions Chemical class 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000035859 Drug effect increased Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DMGNFLJBACZMRM-UHFFFAOYSA-N O[P] Chemical compound O[P] DMGNFLJBACZMRM-UHFFFAOYSA-N 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000006066 glass batch Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000001097 osteosynthetic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明属于生物材料技术领域,具体涉及一种具有生物活性的硼酸盐玻璃抗菌涂层的制备方法及其应用。其制备步骤如下:制备含有灭菌离子的硼酸盐玻璃,将玻璃粉碎筛分;将上述玻璃粉均匀涂覆至植入器材表面,然后经过热处理,使玻璃粉具有黏性,形成覆盖在植入器材表面上的抗菌涂层。该工艺设备简单,容易操作,成本低廉。本发明的涂层具有抗菌性及生物活性,能牢固地涂覆在植入器材表面,能有效改良现有植入材料的生物活性及抗菌性能。The invention belongs to the technical field of biological materials, and in particular relates to a preparation method and application of a borate glass antibacterial coating with biological activity. The preparation steps are as follows: prepare borate glass containing sterilizing ions, crush and sieve the glass; uniformly coat the above-mentioned glass powder on the surface of the implant device, and then undergo heat treatment to make the glass powder viscous and form a covering on the implant. antimicrobial coating on the surface of the device. The process equipment is simple, easy to operate and low in cost. The coating of the invention has antibacterial property and biological activity, can be firmly coated on the surface of implant equipment, and can effectively improve the biological activity and antibacterial performance of existing implant materials.
Description
技术领域technical field
本发明属于生物材料技术领域,具体涉及一种具有生物活性的硼酸盐玻璃抗菌涂层的制备方法及其应用。The invention belongs to the technical field of biological materials, and in particular relates to a preparation method and application of a borate glass antibacterial coating with biological activity.
背景技术Background technique
钛合金(Ti6A14V)由于其优良的力学性能和生物相容性,被广泛的用作承重植入材料,例如接骨板。此类材料的缺点是与人体骨没有直接的键合,而且由于钒元素的存在,使得具有一定的毒性。同时,以接骨板为例,目前治疗骨折的主要方法就是植入接骨板从而进行骨折内固定术。然而,骨折内固定术存在大量术后感染的情况,根据文献报道,其感染率约为5%~20%。其中钉道感染更会造成螺钉松动等严重的后果,给病患带来巨大痛苦。Titanium alloy (Ti6A14V) is widely used as a load-bearing implant material, such as bone plate, due to its excellent mechanical properties and biocompatibility. The disadvantage of this kind of material is that it has no direct bond with human bone, and due to the presence of vanadium element, it has certain toxicity. At the same time, taking the bone plate as an example, the main method for treating fractures at present is to implant the bone plate to perform fracture internal fixation. However, there are a large number of postoperative infections in internal fixation of fractures, and according to literature reports, the infection rate is about 5% to 20%. Wherein nail track infection can cause serious consequences such as screw loosening more, bring great misery to the patient.
可见,以目前的接骨板为例,很多种类的植入器材是存在明显的缺陷的。它们通常不具有抗菌性,不能完全适应手术的要求,人们迫切需要对其改进。It can be seen that, taking the current bone plate as an example, there are obvious defects in many types of implant equipment. They are usually not antibacterial and cannot be fully adapted to the requirements of surgery, and their improvement is urgently needed.
发明内容Contents of the invention
本发明的目的在克服上述不足,提供一种能具有生物活性及抗菌性能的硼酸盐玻璃涂层的制备方法。The object of the present invention is to overcome above-mentioned deficiency, provide a kind of preparation method of the borate glass coating that can have biological activity and antibacterial performance.
本发明提出的具有生物活性及抗菌性能的硼酸盐玻璃涂层的制备方法,具体步骤如下:The preparation method of the borate glass coating with biological activity and antibacterial properties proposed by the present invention, the specific steps are as follows:
(1)向硼酸盐玻璃中加入含有灭菌离子的盐类,研磨混合均匀之后,采用高温熔融法制得玻璃块;将所得含有灭菌离子的玻璃块粉碎筛分得到粒径均一、平均粒径小于50um的玻璃粉;所述灭菌离子为重金属离子,为银离子、锌离子或铜离子中任一种;灭菌离子的加入量为硼酸盐玻璃质量的0.1wt%-15wt%;所述硼酸盐玻璃网络形成体为B2O3,不含或少量含SiO2/或含P2O5,其中B2O3含量大于SiO2/P2O5含量,网络形成体的总分子比例为30~90mol%;网络外体含有CaO,并还含有Na2O、K2O碱金属氧化物以及MgO,SrO碱土金属氧化物;网络外体离子氧化物的总分子比例为5~80mol%;其中CaO和SrO的分子比例各为5~60mol%;(1) Add salts containing sterilizing ions to borate glass, grind and mix evenly, and then use high-temperature melting method to obtain glass blocks; crush and sieve the obtained glass blocks containing sterilizing ions to obtain uniform particle size and average particle size. Glass powder with a diameter of less than 50um; the sterilizing ion is a heavy metal ion, which is any one of silver ion, zinc ion or copper ion; the amount of the sterilizing ion is 0.1wt%-15wt% of the mass of the borate glass; The borate glass network former is B 2 O 3 , containing no or a small amount of SiO 2 /or containing P 2 O 5 , wherein the content of B 2 O 3 is greater than the content of SiO 2 /P 2 O 5 , and the content of the network former is The total molecular ratio is 30-90mol%; the outer network body contains CaO, and also contains Na 2 O, K 2 O alkali metal oxides and MgO, SrO alkaline earth metal oxides; the total molecular ratio of the network outer body ion oxide is 5 ~80mol%; wherein the molecular proportions of CaO and SrO are 5~60mol% respectively;
(2)通过超声振荡将步骤(1)所得玻璃粉均匀分散在溶剂中,然后随着溶剂的挥发,玻璃粉便沉积在植入器材表面;或采用喷涂法,将含有玻璃粉的粘结剂喷涂在植入器材表面;或采用提拉法,将含有玻璃粉的粘结剂粘附在植入器材表面;(2) Uniformly disperse the glass powder obtained in step (1) in the solvent by ultrasonic vibration, and then as the solvent volatilizes, the glass powder is deposited on the surface of the implant device; Spray on the surface of the implanted device; or use the pulling method to adhere the adhesive containing glass powder to the surface of the implanted device;
(3)将步骤(2)已经沉积了玻璃粉末或黏附了玻璃粉末的植入器材放进马弗炉中,在350-400℃温度下烧烬粘结剂,在600~1000℃下保温2-30min,即得所需抗菌涂层。(3) Put the implanted device that has deposited glass powder or adhered glass powder in step (2) into a muffle furnace, burns the binder at a temperature of 350-400°C, and keeps it warm at 600-1000°C for 2 -30min, the desired antibacterial coating is obtained.
利用本发明方法得到具有生物活性及抗菌性能的硼酸盐玻璃涂层在骨修复植入体上的应用。The application of the borate glass coating with biological activity and antibacterial properties on bone repair implants is obtained by using the method of the invention.
利用本发明方法得到具有生物活性及抗菌性能的硼酸盐玻璃涂层在刺激骨细胞生长上的应用。The application of the borate glass coating with biological activity and antibacterial performance in stimulating the growth of bone cells is obtained by using the method of the invention.
利用本发明方法得到具有生物活性及抗菌性能的硼酸盐玻璃涂层在动物体内的应用。The application of the borate glass coating with biological activity and antibacterial performance in animal body obtained by using the method of the invention.
本发明于可以通过玻璃粉的用量来调节所得涂层的厚度,从而调节涂层中灭菌离子的含量。通过热处理的温度及时间来调节所得涂层与植入器材的结合强度。通过灭菌离子的掺入量或玻璃载体的组成来调节所得涂层中灭菌离子的释放速度,从而调节的涂层的生物活性及抗菌效果。通过玻璃粉的组成,各种氧化物的比例能调节玻璃涂层的生物活性和生物降解性,以及对骨细胞生长的刺激作用。The present invention can adjust the thickness of the obtained coating through the amount of glass powder, thereby adjusting the content of sterilizing ions in the coating. The bonding strength between the obtained coating and the implanted device is adjusted by the temperature and time of the heat treatment. The release rate of sterilizing ions in the obtained coating is adjusted by the doping amount of sterilizing ions or the composition of the glass carrier, thereby adjusting the biological activity and antibacterial effect of the coating. Through the composition of the glass powder, the ratio of the various oxides can adjust the bioactivity and biodegradability of the glass coating, as well as the stimulating effect on bone cell growth.
本发明采用离子灭菌的方法,结合了传统植入器材优良的力学性能和硼酸盐玻璃良好的生物活性和特殊结构,以及灭菌离子,例如银离子,其抗菌效率高、对人体危害小、抗菌谱广的优点,工艺设备简单,容易操作,成本低廉,能有效减少手术中由细菌引起的病症,同时应用于骨修复植入体上,有明显的刺激骨细胞生长作用。The invention adopts the method of ion sterilization, which combines the excellent mechanical properties of traditional implant equipment with the good biological activity and special structure of borate glass, and sterilizing ions, such as silver ions, which have high antibacterial efficiency and little harm to the human body , The advantages of broad antibacterial spectrum, simple process equipment, easy operation, low cost, can effectively reduce the disease caused by bacteria in the operation, and at the same time applied to bone repair implants, it can obviously stimulate the growth of bone cells.
附图说明Description of drawings
图1.含银硼酸盐玻璃涂层的接骨板的细胞相容性测试,通过MTT比色法测量其对成骨细胞影响的结果,说明玻璃涂层具有良好的生物相容性。Figure 1. Cytocompatibility test of bone plate containing silver borate glass coating, the results of measuring its effect on osteoblasts by MTT colorimetry, indicating that the glass coating has good biocompatibility.
图2含银硼酸盐玻璃涂层的接骨板的细胞刺激骨细胞生长的测试,通过碱性磷酸酶(ALP)法测其细胞增殖数量,说明玻璃涂层具有优异的生物活性,能刺激骨细胞生长。Figure 2 The test that the cells of the bone plate containing silver borate glass coating stimulate the growth of bone cells, and the number of cell proliferation is measured by the alkaline phosphatase (ALP) method, indicating that the glass coating has excellent biological activity and can stimulate bone cell growth.
图3含银硼酸盐玻璃涂层的接骨板埋入兔子胫骨附近10周后,接骨板表面形成物的物相分析,提示表明在接骨板上已形成了骨组织的无机矿物组成,羟基磷灰石。说明该接骨板具有刺激骨细胞生长的功能。Fig. 3 The phase analysis of the formation on the surface of the bone plate after the silver-borate glass-coated bone plate was embedded near the rabbit tibia for 10 weeks, suggesting that the inorganic mineral composition of bone tissue has formed on the bone plate, hydroxyphosphorus gray stone. It shows that the bone plate has the function of stimulating the growth of bone cells.
具体实施方式Detailed ways
下面通过实施例进一步说明本发明。The present invention is further illustrated below by way of examples.
实施例1含银硼酸盐玻璃涂层的制备Embodiment 1 Preparation of silver-containing borate glass coating
(一)含银量1.0%的硼酸盐玻璃的制备(1) Preparation of borate glass with 1.0% silver content
分别称取2.926g无水碳酸钠,7.107g无水碳酸钾,4.995g碱式碳酸镁,10.294g碳酸钙,5.694g碳酸锶,6.951g二氧化硅,29.473g硼酸,3.419g磷酸二氢钠,0.529g磷酸银。研磨后,充分混合,得到原始配料。Weigh 2.926g anhydrous sodium carbonate, 7.107g anhydrous potassium carbonate, 4.995g basic magnesium carbonate, 10.294g calcium carbonate, 5.694g strontium carbonate, 6.951g silicon dioxide, 29.473g boric acid, 3.419g sodium dihydrogen phosphate , 0.529g silver phosphate. After grinding, mix well to get the raw ingredients.
将配料装入铂金坩埚后,放入1150℃中保温120min,然后将所得的澄清玻璃液倒在已预热的钢板上得到玻璃块。After putting the ingredients into a platinum crucible, put it in a temperature of 1150°C for 120 minutes, and then pour the obtained clear glass liquid on a preheated steel plate to obtain a glass block.
将玻璃块粉碎筛分,得到平均粒径在2-50um左右的玻璃颗粒。The glass block is crushed and sieved to obtain glass particles with an average particle size of about 2-50um.
(二)涂层的制备采用下述方法中任一种:(2) The preparation of the coating adopts any of the following methods:
(1)把步骤(一)中所得的玻璃颗粒洗净干燥之后,称取0.15g装入100ml小烧杯中。(1) After washing and drying the glass particles obtained in step (1), weigh 0.15 g and put it into a 100 ml small beaker.
将同样洗净的接骨板放在烧杯底部,然后量取10ml无水乙醇倒入小烧杯中。Put the same cleaned bone plate at the bottom of the beaker, then measure 10ml of absolute ethanol and pour it into the small beaker.
通过超声振荡15min使得玻璃粉均匀得分散在乙醇中,然后将烧杯放入80℃烘箱中过夜干燥,得到表面均匀沉淀了一层玻璃粉的接骨板。The glass powder was evenly dispersed in ethanol by ultrasonic vibration for 15 minutes, and then the beaker was placed in an oven at 80°C for overnight drying to obtain a bone plate with a uniform layer of glass powder deposited on the surface.
将上述接骨板放入600℃马弗炉中,保温20min中后取出,得到分布均匀的玻璃涂层。Put the above-mentioned bone plate into a muffle furnace at 600°C, keep it warm for 20 minutes, and then take it out to obtain a uniformly distributed glass coating.
(2)将步骤(一)中所得的玻璃颗粒洗净干燥后,称取4.0g装入100ml小烧杯中。量取20ml乙醇,称取1.2g乙基纤维素。搅拌均匀后一起倒入球磨罐中球磨30min,制成浆料。(2) Wash and dry the glass particles obtained in step (1), weigh 4.0 g and put them into a 100 ml small beaker. Measure 20ml of ethanol and weigh 1.2g of ethyl cellulose. After stirring evenly, pour them into a ball mill jar and mill them for 30 minutes to make a slurry.
然后将洗净的接骨板浸渍在浆料中,以1cm/min的速度从浆料中提拉出来,风干之后,得到表面均匀黏附了一层玻璃粉的接骨板。Then the cleaned bone plate was immersed in the slurry, pulled out from the slurry at a speed of 1 cm/min, and after air drying, a bone plate with a layer of glass powder evenly adhered to the surface was obtained.
将上述接骨板放入马弗炉中,以2.5℃/min的速率随炉升温至460℃,保温1h,然后以10℃/min速率升温至660℃,保温15min,从炉中取出,得到分布均匀的玻璃涂层。Put the above-mentioned bone plate into the muffle furnace, raise the temperature with the furnace to 460°C at a rate of 2.5°C/min, keep it for 1h, then raise the temperature to 660°C at a rate of 10°C/min, keep it for 15min, take it out of the furnace, and get the distribution Uniform glass coating.
(3)将步骤(一)中所得的玻璃颗粒洗净干燥后备用。将乙醇与水按照1∶3的比例混合,然后按照0.1g/ml的比例将玻璃粉加入溶液中,一同放入雾化箱中进行雾化,随后由载气携带经过喷头均匀地喷到接骨板表面,风干之后,得到表面均匀沉积了一层玻璃粉的接骨板。(3) Wash and dry the glass particles obtained in step (1) for later use. Mix ethanol and water at a ratio of 1:3, then add glass powder into the solution at a ratio of 0.1g/ml, put them together in an atomization box for atomization, and then be carried by the carrier gas through the nozzle and spray evenly onto the bone After the surface of the plate is air-dried, a bone plate with a layer of glass powder evenly deposited on the surface is obtained.
将上述接骨板放入600℃马弗炉中,保温20min中后取出,得到分布均匀的玻璃涂层。Put the above-mentioned bone plate into a muffle furnace at 600°C, keep it warm for 20 minutes, and then take it out to obtain a uniformly distributed glass coating.
实施例2:含银硼酸盐玻璃涂层的涂层的抗菌性能Example 2: Antimicrobial properties of coatings containing silver borate glass coatings
按照实施例1方法,在玻璃在配方中,分别加入0.265g,0.529g,0.794g,1.058g的磷酸银,分别制得含有AgO为0.5,1.0,1.5和2.0wt%的四种玻璃块,按照实施例2方法获得四种玻璃涂层块的浸提液。另置大肠杆菌ATCC259,金黄色葡萄球菌ATCC25923于试验前转种于血琼脂平板上,35℃孵育18h,然后在血平板上分别挑取大肠杆菌和金黄色葡萄球菌2~3个菌落于肉汤,35℃卵育2h。用微量加样器取一定量的菌液依次加入由低浓度到高浓度排列的浸提液中,结果观察,无肉眼可见生长的最低浸提液浓度为其对该菌的抑菌性能(MIC)。将按一定比例稀释的一定量的菌液接种于2个血平板上,涂布35℃孵育18h。计算血平板上的菌落个数,取平均数计算最初接种菌量。菌落个数低于最初接种菌量的0.1%的最低浸提液浓度为其对该菌的杀(灭)菌能力(MBC)。According to the method of Example 1, 0.265g, 0.529g, 0.794g, and 1.058g of silver phosphate were added to the formula of the glass to prepare four kinds of glass blocks containing AgO of 0.5, 1.0, 1.5 and 2.0wt%, respectively. According to the method of Example 2, four kinds of leaching solutions of glass coating blocks were obtained. Separately place Escherichia coli ATCC259 and Staphylococcus aureus ATCC25923 on the blood agar plate before the test, incubate at 35°C for 18 hours, then pick 2 to 3 colonies of Escherichia coli and Staphylococcus aureus on the blood plate and place them in the broth , 35 ℃ egg incubation 2h. Use a micro-sampler to take a certain amount of bacterial liquid and add it to the extracts arranged from low concentration to high concentration in sequence. The results show that the lowest concentration of the extract without visible growth is its antibacterial performance (MIC ). A certain amount of bacterial solution diluted in a certain proportion was inoculated on two blood plates, and incubated at 35°C for 18 hours. Count the number of colonies on the blood plate, and take the average to calculate the initial inoculum. The minimum concentration of the extract solution at which the number of colonies is lower than 0.1% of the initial inoculum is its bactericidal (killing) ability (MBC) to the bacteria.
结果显示,抗菌硼酸盐玻璃涂层的抑菌性能要比基础玻璃灭菌能力强,不掺银或含银量较少基本上没有抗菌能力。含银量2%的涂层对大肠杆菌和金黄色葡萄球菌的抑菌和杀菌效果都比较好,含银量1%和0.75%的涂层对大肠杆菌的抑菌效果比较明显,但对金黄色葡萄球菌的杀灭效果就差一些(见表1)。随着银含量的增加,灭菌效果显著增加。The results show that the antibacterial performance of the antibacterial borate glass coating is stronger than that of the basic glass, and it has no antibacterial ability if it is not mixed with silver or contains less silver. The bacteriostasis and bactericidal effect of the coating containing 2% silver on E. The killing effect of Staphylococcus aureus is just worse (see Table 1). With the increase of silver content, the sterilization effect increased significantly.
表1银含量为1.5wt%时的灭菌效果对比The sterilization effect comparison when the silver content of table 1 is 1.5wt%
实施例3:含铜及含锌硼酸盐玻璃涂层的抑菌性能Embodiment 3: Bacteriostatic properties of copper-containing and zinc-containing borate glass coatings
按照实施例1所述的方法,在玻璃配方中,将磷酸银换成硫酸铜,分别添加6.818g,13.636g,20.454g CuSO4,分别制得三种铜含量不同的硼酸盐玻璃,并进而制得铜离子质量百分比为5%,10%,15%的含铜硼酸盐玻璃涂层。用同样方法,在玻璃配合料中分别添加氧化锌2.172g,4.344g,6.516g,用同样的方法制得三种锌离子质量百分比为5%,10%,15%的含锌硼酸盐玻璃涂层。According to the method described in Example 1, in the glass formulation, silver phosphate is replaced by copper sulfate, and 6.818g, 13.636g, and 20.454g CuSO are added respectively to make three kinds of borate glasses with different copper contents, and then Copper-containing borate glass coatings with 5%, 10%, and 15% copper ion mass percentages were prepared. In the same way, 2.172g, 4.344g, and 6.516g of zinc oxide were added to the glass batch material respectively, and three kinds of zinc-containing borate glasses with 5%, 10%, and 15% zinc ion mass percentages were prepared in the same way. coating.
采用无菌培养皿中加入已灭菌的普通营养琼脂培养基,使之覆盖整个培养皿底部,厚约2.5mm,再均匀涂浓度为107cfu/ml的大肠杆菌(Escherichia coli)菌液,形成菌液膜。裁取六块10*10*0.5mm3的接骨板,其中上表面分别已经涂覆上述六钟玻璃涂层,将其平放于皿中,37℃下培养24h,观察涂层样品周围细菌生长情况,测量抑菌圈。Add sterilized common nutrient agar medium into a sterile petri dish to cover the entire bottom of the petri dish with a thickness of about 2.5 mm, and then evenly coat the Escherichia coli (Escherichia coli) bacterial solution with a concentration of 10 7 cfu/ml. Formation of bacterial fluid film. Cut out six 10*10*0.5mm 3 osteosynthetic plates, the upper surfaces of which have been coated with the above-mentioned six glass coatings, place them flat in a dish, and incubate them at 37°C for 24 hours to observe the growth of bacteria around the coated samples situation, measure the zone of inhibition.
结果显示,随着铜含量的增加,抑菌圈扩大,抑菌性能得到加强。含锌硼酸盐玻璃涂层的抑菌性能随着锌含量的增加也得到加强,规律与铜离子相似,但其抑菌性能略低于同样质量百分比含量的铜离子所得涂层(见表2)。The results showed that with the increase of copper content, the inhibition zone expanded and the antibacterial performance was strengthened. The antibacterial performance of the zinc-containing borate glass coating is also strengthened with the increase of the zinc content, and the law is similar to that of copper ions, but its antibacterial performance is slightly lower than that of the coating obtained by the same mass percentage of copper ions (see Table 2 ).
表2Table 2
实施例4:抗菌硼酸盐玻璃涂层的生物相容性Example 4: Biocompatibility of Antimicrobial Borate Glass Coatings
按照实施例1方法,在配方中,分别加入0.397g,0.529g,1.058g的磷酸银,分别制得含有AgO为0.75,1.0和2.0wt%的三种玻璃涂层块,所得三种不同银含量的玻璃涂层块分别浸泡在乙醇中24小时,之后用去离子水清洗3次。然后按照1.25cm2表面积对应1ml溶液的比例将玻璃浸泡在DMEM细胞培养基或者α-MEM细胞培养基中。24小时后,去除玻璃块,得到三种玻璃的浸提液,并在其中补充体积比为10%的胎牛血清和1%的青链霉素。According to the method of Example 1, in the formula, add 0.397g, 0.529g, and 1.058g of silver phosphate respectively to make three kinds of glass coating pieces containing AgO that are 0.75, 1.0 and 2.0wt%, respectively, and the gained three kinds of different silver The glass-coated pieces of the content were soaked in ethanol for 24 hours, and then washed 3 times with deionized water. Then soak the glass in DMEM cell culture medium or α-MEM cell culture medium according to the ratio of 1.25 cm 2 surface area to 1 ml solution. After 24 hours, the glass block was removed to obtain three kinds of glass extracts, which were supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin in volume ratio.
然后在浸提液中引入MC3T3E1型成骨细胞,将细胞株以0.2ml/孔的密度种植至96孔的培养皿中。然后将成骨细胞培养在α-MEM培养基中,培养基中添加10%胎牛血清,100U/ml青霉素,100ug/ml的链霉素。未添加玻璃浸提液的培养基作为对照组。所有细胞都培养在37℃下,5%CO2环境中。经过24小时的培养,通过MTT比色法来评价细胞的生长情况。Then, MC3T3E1 osteoblasts were introduced into the extract, and the cell lines were planted in a 96-well culture dish at a density of 0.2 ml/well. Then the osteoblasts were cultured in α-MEM medium, which was supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 ug/ml streptomycin. The culture medium without glass extract was used as the control group. All cells were cultured at 37°C in a 5% CO2 environment. After 24 hours of culture, the growth of cells was evaluated by MTT colorimetry.
结果显示随着硼酸盐玻璃中银含量的提高对细胞损害较大,而含银量1%及0.75%的硼酸盐玻璃浸提液对细胞的毒性较小,含银量2%的硼酸盐玻璃浸提液也在可承受的范围之内(见图1)。The results showed that with the increase of the silver content in the borate glass, the damage to the cells was greater, while the borate glass extracts containing 1% and 0.75% of the silver content were less toxic to the cells, and the boric acid containing 2% silver was less toxic to the cells. Salt glass extracts are also within acceptable limits (see Figure 1).
实施例5:抗菌硼酸盐玻璃涂层的刺激骨细胞生长性能Example 5: Osteocyte Growth Stimulating Properties of Antimicrobial Borate Glass Coatings
按照实施例4制得银含量不同的三种硼酸盐玻璃,并获得三种相应的玻璃涂层块的浸提液。将MC3T3-E1型成骨细胞种在24孔培养皿中,培养在空白培养基或者添加了含银硼酸盐玻璃浸提液的培养基中。经过48小时的培养,用PBS清洗细胞两次,然后放置在500ul浓度为1%的Triton X-100磷酸缓冲液中,利用冻融循环(-80/37℃)将细胞溶解。等份的溶解液分别装在96孔的培养皿中利用分光光度法测量其ALP活性。Three borate glasses with different silver contents were prepared according to Example 4, and three corresponding leaching solutions of glass-coated pieces were obtained. MC3T3-E1 osteoblasts were seeded in 24-well culture dishes and cultured in blank medium or medium supplemented with silver borate glass extract. After 48 hours of culture, the cells were washed twice with PBS, and then placed in 500ul of 1% Triton X-100 phosphate buffer, and the cells were lysed by freeze-thaw cycles (-80/37°C). Aliquots of the lysate were packed in 96-well petri dishes and their ALP activity was measured by spectrophotometry.
结果显示,加入了含银量分别为0%、0.75%、1.0%、2.0%的四组硼酸盐玻璃浸提液的α-MEM与空白的α-MEM培养基对成骨细胞性能造成的影响差别不大(见图2)。结果显示,此三种含银玻璃涂层块都具有优异的生物活性,能刺激骨细胞的增殖。The results showed that the addition of α-MEM and blank α-MEM medium with silver content of 0%, 0.75%, 1.0%, and 2.0% borate glass leaching solutions had different effects on the performance of osteoblasts. The effect is not much different (see Figure 2). The results showed that the three silver-containing glass-coated blocks all had excellent biological activity and could stimulate the proliferation of bone cells.
实施例6:抗菌硼酸盐玻璃涂层在动物体内的作用:Example 6: Effect of Antimicrobial Borate Glass Coating in Animals:
按照实施例1,取由沉降法制得涂有含氧化银1wt%的硼酸盐玻璃涂层接骨板(20x2x0.5mm),埋入到10只兔子的胫骨的表面,然后在兔子的胫骨附近注入含有金黄色葡萄球菌ATCC25923乳浊溶液0.1毫升,制造含有细菌的动物模型。在接骨板埋入兔子的实验期间,10只兔子没有发现炎症症状。在10周以后从兔子体内取出埋入的接骨板,没有发现骨组织坏死迹象,说明接骨板涂层有抗菌功能;分离接骨板的表面形成物,进行XRD表面分析(见图3),提示表明该表面形成物含有骨组织中无机矿物,羟基磷灰石,说明在兔子体内的接骨板对骨细胞生长有一定的刺激作用。According to embodiment 1, get and be coated with the borate glass coating osteosynthesis plate (20x2x0.5mm) that contains silver oxide 1wt% by sedimentation method, be embedded in the surface of the tibia of 10 rabbits, inject near the tibia of rabbit then Contain 0.1 ml of Staphylococcus aureus ATCC25923 emulsified solution to make animal models containing bacteria. During the experiment with bone plate implantation in rabbits, no signs of inflammation were found in 10 rabbits. After 10 weeks, the embedded bone plate was taken out from the rabbit body, and no signs of bone tissue necrosis were found, indicating that the bone plate coating had an antibacterial function; the surface formations of the bone plate were separated, and XRD surface analysis was performed (see Figure 3), and the prompt showed The surface formation contains inorganic minerals in bone tissue, hydroxyapatite, indicating that the bone plate in the rabbit has a certain stimulating effect on the growth of bone cells.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010209082 CN101884807B (en) | 2010-06-24 | 2010-06-24 | A kind of preparation method and application of borate glass antibacterial coating with biological activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010209082 CN101884807B (en) | 2010-06-24 | 2010-06-24 | A kind of preparation method and application of borate glass antibacterial coating with biological activity |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101884807A true CN101884807A (en) | 2010-11-17 |
CN101884807B CN101884807B (en) | 2013-06-26 |
Family
ID=43071003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010209082 Expired - Fee Related CN101884807B (en) | 2010-06-24 | 2010-06-24 | A kind of preparation method and application of borate glass antibacterial coating with biological activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101884807B (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102380127A (en) * | 2011-11-09 | 2012-03-21 | 同济大学 | Preparation method and application of antibacterial glass coating of antibacterial bone fracture plate |
CN103285425A (en) * | 2012-03-01 | 2013-09-11 | 中国科学院上海硅酸盐研究所 | Bio-coating with good anti-degradation property and antibacterial property, and preparation method thereof |
CN103459338A (en) * | 2011-03-28 | 2013-12-18 | 康宁股份有限公司 | Antimicrobial action of copper in glass |
WO2016089731A1 (en) * | 2014-12-04 | 2016-06-09 | 3M Innovative Properties Company | Antimicrobial compositions comprising bioglass |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
CN106999631A (en) * | 2014-12-11 | 2017-08-01 | 柯惠有限合伙公司 | Antimicrobial coating and the method for preparing this coating for medicine equipment |
CN111919857A (en) * | 2020-08-12 | 2020-11-13 | 高时(厦门)石业有限公司 | Preparation method of sterilization powder, sterilization powder and antibacterial inorganic artificial stone using sterilization powder |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4478904A (en) * | 1981-04-08 | 1984-10-23 | University Of Florida | Metal fiber reinforced bioglass composites |
CN1539512A (en) * | 2003-10-31 | 2004-10-27 | 中国科学院上海硅酸盐研究所 | A kind of medical biological implant and its preparation method |
CN1982504A (en) * | 2005-12-16 | 2007-06-20 | 中国科学院金属研究所 | Production of titanium and titanium-alloy glass ceramic coating |
-
2010
- 2010-06-24 CN CN 201010209082 patent/CN101884807B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4478904A (en) * | 1981-04-08 | 1984-10-23 | University Of Florida | Metal fiber reinforced bioglass composites |
CN1539512A (en) * | 2003-10-31 | 2004-10-27 | 中国科学院上海硅酸盐研究所 | A kind of medical biological implant and its preparation method |
CN1982504A (en) * | 2005-12-16 | 2007-06-20 | 中国科学院金属研究所 | Production of titanium and titanium-alloy glass ceramic coating |
Non-Patent Citations (1)
Title |
---|
肖伟 等: "硼酸盐玻璃在生物材料领域中的应用", 《中国组织工程研究与临床康复》 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103459338A (en) * | 2011-03-28 | 2013-12-18 | 康宁股份有限公司 | Antimicrobial action of copper in glass |
CN102380127A (en) * | 2011-11-09 | 2012-03-21 | 同济大学 | Preparation method and application of antibacterial glass coating of antibacterial bone fracture plate |
CN103285425A (en) * | 2012-03-01 | 2013-09-11 | 中国科学院上海硅酸盐研究所 | Bio-coating with good anti-degradation property and antibacterial property, and preparation method thereof |
CN103285425B (en) * | 2012-03-01 | 2015-01-07 | 中国科学院上海硅酸盐研究所 | A kind of biological coating with good anti-degradation and antibacterial properties and its preparation method |
US11039619B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US12121030B2 (en) | 2014-02-19 | 2024-10-22 | Corning Incorporated | Aluminosilicate glass with phosphorus and potassium |
US11751570B2 (en) | 2014-02-19 | 2023-09-12 | Corning Incorporated | Aluminosilicate glass with phosphorus and potassium |
US11470847B2 (en) | 2014-02-19 | 2022-10-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11464232B2 (en) | 2014-02-19 | 2022-10-11 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
WO2016089731A1 (en) * | 2014-12-04 | 2016-06-09 | 3M Innovative Properties Company | Antimicrobial compositions comprising bioglass |
JP2017536402A (en) * | 2014-12-04 | 2017-12-07 | スリーエム イノベイティブ プロパティズ カンパニー | Antibacterial composition comprising bioglass |
CN106999622A (en) * | 2014-12-04 | 2017-08-01 | 3M创新有限公司 | Antimicrobial compositions comprising bio-vitric |
CN106999631A (en) * | 2014-12-11 | 2017-08-01 | 柯惠有限合伙公司 | Antimicrobial coating and the method for preparing this coating for medicine equipment |
CN111919857A (en) * | 2020-08-12 | 2020-11-13 | 高时(厦门)石业有限公司 | Preparation method of sterilization powder, sterilization powder and antibacterial inorganic artificial stone using sterilization powder |
Also Published As
Publication number | Publication date |
---|---|
CN101884807B (en) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884807A (en) | A kind of preparation method and application of borate glass antibacterial coating with biological activity | |
Rau et al. | Cu-releasing bioactive glass coatings and their in vitro properties | |
Ege et al. | Borate bioactive glasses (BBG): bone regeneration, wound healing applications, and future directions | |
Geng et al. | Strontium incorporation to optimize the antibacterial and biological characteristics of silver-substituted hydroxyapatite coating | |
Cao et al. | Ag‐loaded MgSrFe‐layered double hydroxide/chitosan composite scaffold with enhanced osteogenic and antibacterial property for bone engineering tissue | |
Wang et al. | Evaluation of three-dimensional silver-doped borate bioactive glass scaffolds for bone repair: Biodegradability, biocompatibility, and antibacterial activity | |
Akhtar et al. | Electrophoretic deposition of ferulic acid loaded bioactive glass/chitosan as antibacterial and bioactive composite coatings | |
CN102380127A (en) | Preparation method and application of antibacterial glass coating of antibacterial bone fracture plate | |
Siek et al. | Evaluation of antibacterial activity and cytocompatibility of α-TCP based bone cements with silver-doped hydroxyapatite and CaCO3 | |
Miola et al. | Antibiotic-free composite bone cements with antibacterial and bioactive properties. A preliminary study | |
Shao et al. | Silver‐containing biomaterials for biomedical hard tissue implants | |
Swain et al. | Dual action of polarised zinc hydroxyapatite-guar gum composite as a next generation bone filler material | |
Dong et al. | Gallium-doped titania nanotubes elicit anti-bacterial efficacy in vivo against Escherichia coli and Staphylococcus aureus biofilm | |
CN100551450C (en) | A kind of preparation method of antibacterial bioactive titanium coating | |
Taye | Biomedical applications of ion-doped bioactive glass: A review | |
Zhang et al. | Novel ternary vancomycin/strontium doped hydroxyapatite/graphene oxide bioactive composite coatings electrodeposited on titanium substrate for orthopedic applications | |
Xu et al. | An injectable gellan gum-based hydrogel that inhibits Staphylococcus aureus for infected bone defect repair | |
Banerjee et al. | Effects of aloe vera gel extract in doped hydroxyapatite-coated titanium implants on in vivo and in vitro biological properties | |
Zahid et al. | Biological behavior of bioactive glasses and their composites | |
Fernandes et al. | Intrinsic antibacterial borosilicate glasses for bone tissue engineering applications | |
Saqaei et al. | Effects of adding forsterite bioceramic on in vitro activity and antibacterial properties of bioactive glass-forsterite nanocomposite powders | |
O'sullivan et al. | Deposition of substituted apatites with anticolonizing properties onto titanium surfaces using a novel blasting process | |
Popescu-Pelin et al. | Antimicrobial and cytocompatible bovine hydroxyapatite-alumina-zeolite composite coatings synthesized by pulsed laser deposition from low-cost sustainable natural resources | |
Pan et al. | Iron-doped brushite bone cement scaffold with enhanced osteoconductivity and antimicrobial properties for jaw regeneration | |
EP3509650A1 (en) | Implantable medical devices having a coating layer with antimicrobial properties based on nanostructured hydroxyapatite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130626 Termination date: 20160624 |
|
CF01 | Termination of patent right due to non-payment of annual fee |